EYPT
EyePoint, Inc.Company with tickers: EYPT
CIK
1314102
CUSIP
30233G209
Shares Outstanding
83,841,298
Website
https://www.eyepoint.bio
Investor Relations
https://eyepoint.bio/press-releases/
13F Activity (30d)
51 filings
48 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | — | ||||
| Net Income | — | ||||
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| United States | $45,270,000 | $42,049,000 | $29,979,000 |
| China | $648,000 | $1,124,000 | $1,292,000 |
| United Kingdom | $100,000 | $100,000 | $100,000 |
By Product & Service (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| License And Collaboration Agreement | $30,797,000 | $38,496,000 | $16,734,000 |
| Royalty | $989,000 | $1,613,000 | $13,041,000 |
| YUTIQ Product | $14,200,000 | $3,100,000 | $1,600,000 |
| Product | $14,232,000 | $3,164,000 | $1,596,000 |